FDA to consider first CRISPR therapy October 30, 2023 AutoBot Uncategorized 0 An advisory committee is meeting Oct. 31 to discuss an experimental drug for sickle cell disease, which could be the first approved therapy made with CRISPR technology — but the candidate faces skepticism.